Drug Targets Flashcards

1
Q

Name two types of drugs that can act on receptors, and their actions:

A

Agonists (or inverse agonists)- directly bind and open ion channels or through transduction mechanisms activate/inhibit enzymes, modulate ion channels or lead to DNA transcription.

Antagonists- block endogenous mediators and produce no effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do ion channels provide a drug target and how do they work?

A

Ion channels sit in the lipid membrane and may either be blocked to produce no ion flow, or modulated to increase or decrease opening probability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the three types of drugs which act on enzymes to produce their effects?

A

Inhibitors block the normal enzymic reaction.
False substrates lead to abnormal metabolite production.
Prodrugs lead to an active drug being produced.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How may drugs act on transporters to produce their effects?

A

They may lead to normal transport.
Inhibitors may block transport.
False substrates may lead to accumulation of an abnormal compound.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Receptors serve as recognition sites for specific endogenous compounds or ligands. What are three classes of these compounds, with examples?

A
  1. Neurotransmitters e.g. noradrenaline (NA)
  2. Hormones e.g. adrenaline (released from adrenal medulla and acts on the heart)
  3. Local hormones/autacoids e.g prostaglandins (released and act upon nearby tissue)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How many binding sites do receptors have?

A

At least one (often more than 1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are ligands, and what two classes can they be?

A

Chemicals which bind to receptors.
Endogenous e.g. ACh
Exogenous e.g. atropine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What it the difference between specificity and selectivity?

A

Specificity means that the receptor will bind only one compound.
Selectivity means that the receptor will select which compound it binds based on the shape of the compound and the binding sites on the receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is affinity?

A

Affinity is the attraction of a ligand/drug for a receptor. For binding to a receptor to occur the drug and receptor must have affinity for each other.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is efficacy?

A

This is the intrinsic activity of the drug which can be between 1 (maximum effect) and 0 (no effect) to describe the strength at which an effect is produced.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In terms of affinity and efficacy, how do agonists and antagonists differ?

A

Agonists have affinity and efficacy (mimics).

Antagonists have affinity and NO efficacy (blocks).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name three important features of receptor structure in terms of function:

A
  1. Specificity for ligand (including the stereospecificity).
  2. Verification of receptor family subtypes (sequencing).
  3. Structure confers functionally important characteristics for intracellular signalling (transduction).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Are drugs totally specific for a receptor family? And what is a consequence of this (example)?

A

No- this can lead to unwanted side effects such as anti-histamines being drowsy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the difference between receptor families and subtypes?

A

Receptor families all have 1 endogenous ligand (e.g. histamine, dopamine).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What two properties is drug action dependent on, and what do these mean?

A
  1. Drug properties- selectivity for receptor subtypes.

2. Tissue properties- distribution of receptor subtypes throughout the body e.g. histamine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the roles of different family subtypes in relation to histamine?

A

H1- skin, allergic reactions
H2- stomach acid secretion
H3- CNS, ileum and cardiac tissue, often presynaptic or autoregulatory

This means drugs need to target a specific subtype in order to avoid side effects from other subtypes e.g. drugs targeting H1 may also act on H3 and produce adverse effects in non-target organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Define selectivity (of receptors) and give an example of how this can lead to beneficial or adverse effects:

A

This is the preferential binding to a certain subtype which leads to a greater effect than other subtypes.

This is important in salbutamol which binds to B2 at lungs rather than B1 at heart when treating asthma. Antihistamines are selective for H1 receptors.

A lack of selectivity can lead to unwanted effects, such as fenoterol and propranolol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are some of the benefits of selectivity in relation to histamine receptors?

A

H1 antagonists (antihistamines) can be used for treatment of hayfever and allergy (e.g. chloropheniramine, loratidine).

H2 antagonists can be used for inhibition of gastric acid secretion (e.g. cimetidine).

H3 antagonists used as experimental tools for treating pain and inflammation (target CNS) (e.g. thioperamide).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe a situation where there is non-receptor specificity/selectivity:

A

NSAIDS can lead to problems with ulcers and uncontrolled bleeding. COX II inhibitors are selective for the inducible form of COX which have little effect on the constitutive form (e.g. rofecoxib, celecoxib).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Name the four receptor theories:

A
  1. Receptor occupancy theory- drug effect is proportional to the number of receptors occupied.
  2. Rate theory- drug effect is proportional to the rate of occupancy.
  3. Two state model- receptors exist in the active or inactive form.
  4. Floating receptor model- the drug receptor complex may interact with a variety of effectors in the membrane to produce its effect.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the receptor occupancy theory and how this can be represented graphically:

A

An equilibrium exists between the drug and receptors being together or apart, with the response proportional to the receptor-drug together.

This is a logarhytmic relationship between concentration and fractional occupancy. This produces a sigmoidal relationship with log concentration values, where Ka is the constant which gives 50% occupancy (measure of affinity).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is meant by ‘receptor plasticity’, and what is it responsible for over time?

A

Receptor states and populations can be altered by physiological, pharmacological or pathological states to alter the number of receptors.

This plasticity is responsible for the changes that occur in the effectiveness of chronic drugs/endogenous compounds over time e.g. insulin resistance, morphine tolerance etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe the four situations which arise from the two-state receptor model:

A
  1. No ligand- equilibrium favours R (resting state).
  2. Full agonist- strong preference for R+ (active state)- equilibrium strongly shifted to R+.
  3. Partial agonist- weak preference for R+- equilibrium partially shifted to R+.
  4. Antagonist- no preference- equilibrium not shifted, however, this prevents agonist binding.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Name the four receptor families and what they are linked to:
How are these families grouped?

A
  1. Ionotropic- linked to ion channels.
  2. Metabotropic- g-protein coupled.
  3. Catalytic- linked to kinases (phosphorylating enzymes).
  4. Nuclear/intracellular-linked to gene transcription.

Families are grouped according to structure and signal transduction system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the general structure of ligand-gated ion channels?

A

Generally a series of 4-5 subunits which form a pore in the membrane, with an extracellular amino terminal ligand binding domain and an extracellular carboxy terminal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the general structure of G-protein coupled receptors?

A

Generally have 7 transmembrane spanning domains with two binding sites, one on the extracellular N terminal and one in the receptor itself. There is an intracellular carboxy G-protein coupling domain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is the general structure of kinase-linked receptors?

A

Single transmembrane spanning domain with an extracellular amino binding domain and an intracellular catalytic carboxy domain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is the general structure of intracellular receptors?

A

These have no membrane and have a carboxy teminal binding domain and a DNA binding domain (zinc fingers).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

How do ionotropic receptors fucntion?

A

These act very fast. The binding of the agonist causes a conformational change in the receptor which leads to ion channel opening.

Depending on which receptor is involved, different agonists can can an increase in channel-opening time (nAChR) or an increase in channel conductance (glutamate).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What type of receptor is nACh, and what is its structure?

A

It is an ionotropic receptor and consists of 5 subunits (2 alpha, 2 beta and 1 gamma), where there are two binding sites between the alpha subunits and the gamma subunit where ACh can bind, causing a change in shape so ions can flow through.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What type of receptor is GABA-A and what is its structure?

A

It is an ionotropic receptor and consists of 5 subunits. Binding to either the benzodiazepine (diazepam) or barbiturate (pentobarbitone) binding site enhances GABA binding and and increases rate or duration of channel opening.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

How do G-protein linked receptors function?

A

These work fast (but slower than ionotropic receptors). Binding of the agonist causes G-protein activiation leading to opening or closing of an ion channel or the generation of second messengers (e.g. cAMP, IP3) to produce a biological effect.

In the resting state there is no binding of the ligand and a(GDP)-BY is linked. Upon binding of the ligand, a(GDP) links to the receptor and produces GTP while BY links to the target 2, and a(GTP) links to target 1. GTP is then hydrolysed and returns to resting state.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Name the three G-protein coupled receptor families:

A

Gs (stimulatory), Gi (inhibitory) and Gq.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Name two examples of G-protein linked receptors:

A

mAChR and adrenoreceptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

How do Gs and Gi second messenger systems carry out their functions in relation to adenylate cyclase (AC) and cAMP?

A

Gs proteins cause a positive effect on AC to increase cAMP, activating protein kinase.
Gi proteins cause a negative effect on AC to decrease cAMP.

36
Q

What are protein kinases, and how do they function?

A

Protein kinases are enzymes that attach phosphate groups to proteins to cause changes in structure and function such as PKA and PKC.

Sometimes third messengers are operated by protein kinase activation leading to gene regulation.

37
Q

What is bi-directional control in relation to G-proteins?

A

This allows control of a target enzyme by different receptor-G protein complexes, allowing different receptors to exert opposing effects on the target enzyme, such as Gs and Gi.

38
Q

How do Gq second messenger systems carry out their functions in relation to phospholipids?

A

Gq activates phospholipids, which convert PIP2 into DAG and IP3, allowing calcium release (via IP3) and protein kinase activation (PKC), which alongside DAG phosphorylates substrates leading to store-operates TRP Ca2+ channel opening, hence muscle contraction.

39
Q

How do catalytic receptors function?

A

Tyrosine-kinase and guanylate cyclase-linked receptors take days and minutes to function respectively as the former is involved in gene transcription. This is mainly cell growth and differentiation.

In all cases the receptors trigger a kinase cascade. Some possess intrinsic kinase activity (insulin, growth factor), others associate with kinases on agonist binding (cytokines, Jaks).

Transduction involves dimerisation of receptors and autophosphorylation of tyrosine residues which acy as acceptors for the SH2 domain proteins to control cell function.

40
Q

Name three types of drugs which can act on catalytic receptors:

A

Growth factors and hormones (e.g. insulin) and cytokines.

41
Q

What are the two important pathways involved with catalytic receptors, and what cellular process are they involved in?

A

Ras/raf/MAP kinase (cell differentiation)

Jak/Stat (inflammation)

42
Q

How does the Ras/raf/MAP kinase pathway function?

A

Growth factor binds to the receptor domain and conformational change causes dimerisation. Tryrosine autophosphorylation results in Grb2 phosphorylation, activating Ras and Raf, leading to a kinase cascade.

43
Q

How does Jak/Stat pathway function?

A

Cytokine binds to dimer cause conformational change, phosphorylating the receptor and Jak, forming a dimer with Stat upon phosphorylation.

44
Q

How do intracellular receptors function?

A

These are slow acting and long lasting as they are to do with gene transcription. Ligands need to penetrate the cell membrane so often lipid soluble.

They bind to highly conserved regions of DNA attached to variable ligand-binding and transcriptional control domains. The end result is an alteration in gene transcription and protein synthesis.

45
Q

What are some examples of ligands acting on intracellular receptors?

A

Steroid hormones e.g. ostetrogen, cortisol and vitamin A.

46
Q

What shape is a general agonist binding curve, and what axis labels are present?

A

Sigmoidal.
x- log concentration (M)
y- response (%)

47
Q

What is the function of an organ bath?

A

Known amounts of drug can be added to a tissue and the response can be measured. The tissue is kept alive by the organ bath conditions.

48
Q

How is agonist potency defined?

A

EC50 (or pD2- -log of EC50)
This is the effective concentration that produces 50% of the maximum effect. ED2 would be the effective dose which produces this.

49
Q

If EC50= 10^-7, what would pD2 equal?

A

-7

50
Q

If EC50 is lowered, what would happen to the agonist potency?

A

It would decrease (more drug is required to produce same effect).

51
Q

What would a concentration-response curve illustrating the effect of adding varying antagonist to fixed agonist concentrations look like, with the x axis representing antagonist concentration?

A

Negatively sigmoidal, that is, increasing antagonist concentrations would decrease the response of the tissue. Log IC50 would represent the concentration of antagonist which reduces response by half.

52
Q

What would a concentration-response curve illustrating the effect of adding a fixed antagonist concentration to varying agonist concentrations look like, with the x axis representing agonist concentration?

A

This would be a positive sigmoid, with varying degrees of curve compression and shifting depending on the ratio of antagonist: agonist. The less antagonist present, the less effected the agonist curve will be.

53
Q

What is competitive reversible antagonism, and some examples of it?

A

This is when the antagonist directly competes with the agonist for binding to the receptor. Examples are propranolol at B1 receptors and atropine at M.

54
Q

How is competitive reversible antagonism represented graphically, and what is the potency measurement?

A

This causes a parallel right shift in the curve, with no depression in maximal response, however, the maximal response occurs at a higher agonist concentration than in the absence of the antagonist.

The potency measure is pA2, which is a measure of how far the curve is right shifted. The higher the number, the more potent the antagonist.

55
Q

How can pA2 be defined and calculated?

A

pA2 is the negative log concentration which causes a 2-fold shift in the concentration-response curve.

pA2 = pAx + log (x-1) where x is the concentration ratio and pAx is the -log of antagonist concentration.

x can be derived from
EC50 (presence of antagonist)/ EC50 (absence of antagonist)
OR
Antilog [pD2 (absence of antagonist) - pD2 (presence of antagonist)].

56
Q

What is competitive irreversible antagonism, and what are some examples of it?

A

The antagonist competes directly with the antagonist for receptor binding but binds with greater affinity (covanlently). Examples are phenoxybenzamine at H1 receptors.

57
Q

How is competitive irreversible antagonism represented graphically, and what is the potency measure?

A

The addition of this antagonist causes a non-parallel rightwards shift in the curve, with depression steepening with increasing antagonist concentrations. If the concentration of the antagonist is low enough, the spare receptor family may allow the curve to be right shifted with no depression.

The potency measure is pD2’ and measures the depression of the curve.

58
Q

How is pD2’ defined and calculated?

A

pD2’ is the negative log concentration of the antagonist which reduces the maximum effect of the agonist by half.

pD2’ = pDx + log (x - 1) where pDx is the -log of antagonist concentration and x is the depression of the maximal response.

x can be calculated as Maximal response in absence of antagonist/ Maximal response in presence of antagonist.

59
Q

What is the spare receptor theory and what is its role in competitive irreversible antagonism?

A

This is the theory that agonists only need to bind to a few receptors to produce a response, so if there are spare receptors present once antagonist has bound, the agonist is still able to bind to the spare receptors and produce a response.

60
Q

What is non-competitive antagonism and how does it act (examples)?

A

This is where the antagonist does not bind to the same receptor and the agonist, nor does it alter agonist-receptor binding.

It acts by interfering with the cascade of events initiated by agonist-receptor binding e.g. Ca2+ channel blockade.

Examples include verapamil antagonism of histamine.

61
Q

How is non-competitive reversible antagonism represented graphically, and what is the potency measurement?

A

It is seen as a rightward shift in the curve with a depression in max response always (no spare receptor theory as it does not compete for receptor sites).

The potency measurement is pD2’

62
Q

How could you tell the difference between non-competitive antagonism and competitive irreversible antagonism?

A

At low concentrations of the antagonist, the curve will be right shifted (but not depressed) with the competitive antagonism because of the spare receptor theory. In non-competitive the curve will always be depressed.

63
Q

What is physiological antagonism? Give an example.

A

This is when the actions of two agonists work at different receptor types to have opposing effects (hence antagonise each other).

Histamine acting at H1 receptors to cause bronchoconstriction and adrenaline acting at B2 receptors to cause bronchodilation. This is good for homeostatic control.

64
Q

What is a partial agonist, how do they work? Give an example.

A

A partial agonist show full receptor occupancy but do not elict a maximal response. The have affinity but efficacy smaller than 1 (vs the full agonist with efficacy=1). They can act as antagonists to full agonists.

Example is methysergide at 5HT receptors.

65
Q

How is partial agonism represented graphically, and what is the potency measurement?

A

At low agonist concentrations the agonist and partial agonist effects add together to increase the effect. At high concentrations the partial agonist gets in the way of agonist binding and diminishes the response.

66
Q

What are inverse agonists and how do they function?

A

Some receptors show constitutive activity. They have negative efficacy so they turn the receptor off and reduce the activity (binds like a competitive reversible antagonist), so it gets in the way of agonist binding.

Ligands showing a preference for binding to the resting state shift the equilibrium towards this state and reduce the level of constitutive activation.

67
Q

How is inverse agonism represented graphically?

A

This is in the opposite direction of the normal curves and is due to a reduction in efficacy below zero.

68
Q

What is an example of an inverse agonist?

A

Benzodiazepine receptor.

69
Q

Give an example of metabotropic receptor desensitisation (receptor state change):

A

B1 adrenoreceptor where agonist binding not affected by unable to activate AC.
A result of BARK phosphorylating a serine residue, blocking signalling between the signalling receptor and BY-a complex.

70
Q

Name the two types of desensitisaton, and give an example of each:

A
  1. Homologous- B1 adrenoreceptor.

2. Heterologous- PKA, PKC

71
Q

What effect does chronic agonist have on receptor populations, and give an example?

A

Leads to down regulation e.g. chronic salbutamol can cause internalisation of receptors which leads to fewer receptors available for stimulation and reduced bronchodilation.

72
Q

What effect does chronic antagonist have on receptor populations and give an example?

A

Leads to up regulation e.g. chronic propanolol can cause increased synthesis of B1 receptors in the heart and lead to less antagonism and reduced effect.

73
Q

Name three ways in which receptor changes are important clinically:

A
  1. Tolerance- down regulation necessitates an increase in drug dose to produce the same effect.
  2. Adverse effects
  3. Therapeutic effects
74
Q

Give two examples of tolerance:

A

Morphine and salbutamol

75
Q

Give an example of the adverse effects of receptor changes:

A

Antipsychotics (D2 antagonists). Chronic haloperidol increases the number of striatal D2 receptors and leads to tardive dyskinesia.

76
Q

Give an example of a therapeutic effect of receptor changes:

A

Tricyclic anti-depressants, therapeutic effects take 2-4 weeks, consistent with down-regulation of B and a2 adrenoreceptors and 5HT2 receptors.

77
Q

What are non-receptor mediated drugs?

A

Drugs that act indirectly (through endogenous neurotransmitter) by modifying its synthesis, storage or release.

78
Q

Give an example of a non-receptor drug:

A

Amphetamine (reduced NA levels in synapse).

79
Q

Name three other non-receptor drug targets and the drugs which target them:

A
  1. Enzymes (COX inhibitors).
  2. Carrier proteins (TCAs and SSRIs)
  3. Ion channels (Na+ channels)
80
Q

Give two examples of enzyme use as drug targets:

A
  1. NSAIDS and COX (ibuprofern, diclofenax) used to treat pain and inflammation.
  2. ACE inhibitors and angiotensin converting enzyme (captopril, enalaprilat) used to treat hypertension.
81
Q

What are the effects of COX induced prostaglandins PGF2, PGD2 and PGE2?

A

PGF2- bronchoconstriction
PGD2- inhibits aggregation of platelets, vasodilator
PGE2- vasodilator

82
Q

What are some of the effects of COX inhibition by COXI/II?

A

Decreased pain, inflammation and fever.

Reduce homeostatic pathways involved in kidney function and maintenance of gastric mucosa.

83
Q

Give two examples of COXII selective inhibitors and describe some of their benefitial/adverse effects:

A

Rofecoxib and celecoxib.

Less adverse GI effects, but renal COX inhibition, cardiovascular effects and hepatic effects (with lumiracoxib).

84
Q

What type of drugs interact with carrier proteins, and what are some examples of them?

A

These drugs often act on monoamine neurotransmitter uptake proteins, such as fluoxetine (Prozac) an SSRI, and sibtramine (Reductil) an SNRI (initially from anti-depressant venalfaxine).

85
Q

How does fluoxetine act as an anti-depressant?

A

Reuptake removes 5HT receptor from synaptic membrane, blocking 5HT with fluoxetine increases its levels in the synapse. Depression is thought to result from 5HT, so increasing levels has an anti-depressant effect.

86
Q

How do ion channels act as sites for drugs, and what are some examples of this happening?

A

Voltage gatesd ion channels may be blocked by local anaethetics (block Na+) or Ca2+ channels may be blocked by verapamil and nifedipine.

Antiepileptic drugs (phenytoin), antidysrhythmic drugs (disopyramide) and toxins may block channels.

Channels may also be blocked from inactivation by veratridine, toxins and herbicides.